782493-24-7

Basic information

• Product Name: 1(2H)-Pyridinecarboxylic acid, 4-[3-(ethoxycarbonyl)phenyl]-3,6-dihydro-, 1,1-dimethylethyl ester
• CAS NO: 782493-24-7
• Molecular Formula: C19H25NO4
• Molecular Weight: 331.412
• Mol File: 782493-24-7.mol

Chemical Properties

• CAS DataBase Reference: 1(2H)-Pyridinecarboxylic acid, 4-[3-(ethoxycarbonyl)phenyl]-3,6-dihydro-, 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 1(2H)-Pyridinecarboxylic acid, 4-[3-(ethoxycarbonyl)phenyl]-3,6-dihydro-, 1,1-dimethylethyl ester(782493-24-7)
• EPA Substance Registry System: 1(2H)-Pyridinecarboxylic acid, 4-[3-(ethoxycarbonyl)phenyl]-3,6-dihydro-, 1,1-dimethylethyl ester(782493-24-7)

Safety Data

• Hazardous Substances Data: 782493-24-7(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
1(2H)-Pyridinecarboxylic acid, 4-[3-(ethoxycarbonyl)phenyl]-3,6-dihydro-, 1,1-dimethylethyl ester is used as a tautomerase ligand for [application reason] in the pharmaceutical industry. Its unique structure and properties make it a valuable compound for research and development of new drugs and treatments.
Used in Research and Development:
In the field of research and development, 1(2H)-Pyridinecarboxylic acid, 4-[3-(ethoxycarbonyl)phenyl]-3,6-dihydro-, 1,1-dimethylethyl ester is used as a key compound for [application reason] in the development of novel drugs and treatments. Its potential anti-inflammatory and anti-cancer properties make it a promising candidate for further study and potential medical applications.
Used in Drug Design and Synthesis:
1(2H)-Pyridinecarboxylic acid, 4-[3-(ethoxycarbonyl)phenyl]-3,6-dihydro-, 1,1-dimethylethyl ester is utilized as a building block or intermediate in the design and synthesis of new pharmaceutical compounds. Its unique structure allows for the creation of novel drug candidates with potential therapeutic benefits.
Used in Drug Delivery Systems:
In the development of drug delivery systems, 1(2H)-Pyridinecarboxylic acid, 4-[3-(ethoxycarbonyl)phenyl]-3,6-dihydro-, 1,1-dimethylethyl ester may be used as a component to enhance the delivery, bioavailability, and therapeutic outcomes of various drugs. Its properties could be harnessed to improve the efficacy of existing treatments and potentially reduce side effects.
Used in Anti-inflammatory and Anti-cancer Applications:
1(2H)-Pyridinecarboxylic acid, 4-[3-(ethoxycarbonyl)phenyl]-3,6-dihydro-, 1,1-dimethylethyl ester is explored for its potential use as an anti-inflammatory and anti-cancer agent. Its properties may contribute to the development of new treatments for various inflammatory and cancer-related conditions, offering patients improved options for managing their health.

Upstream product

• 79099-07-3 N-tert-butyloxycarbonylpiperidin-4-one 
• 58313-23-8 3-iodobenzoic acid methyl ester 
• 375853-82-0 tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydro-1(2H)-pyridinecarboxylate 
• 4334-87-6 [3-(ethoxycarbonyl)phenyl]boronic acid 
• 138647-49-1 4-Trifluoromethanesulfonyloxy-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester 

Downstream Products

• 1263775-59-2 N-methyl-3-{1-[2-(5-methyl-3-trifluoromethyl-pyrazol-1-yl)-acetyl]-piperidin-4-yl}-N-((R)-1-phenyl-ethyl)-benzamide 
• 1263776-11-9 3-{1-[2-(5-methyl-3-trifluoromethyl-pyrazol-1-yl)-acetyl]-piperidin-4-yl}-benzoic acid ethyl ester 
• 1263776-13-1 3-{1-[2-(5-methyl-3-trifluoromethyl-pyrazol-1-yl)-acetyl]-piperidin-4-yl}-benzoic acid 
• 1263775-57-0 3-{1-[2-(5-methyl-3-trifluoromethyl-pyrazol-1-yl)-acetyl]-piperidin-4-yl}-N-(R)-1,2,3,4-tetrahydro-naphthalene-1-yl-benzamide 
• 1263775-58-1 N-methyl-3-{1-[2-(5-methyl-3-trifluoromethyl-pyrazol-1-yl)-acetyl]-piperidin-4-yl}-N-(R)-1,2,3,4-tetrahydro-naphthalene-1-yl-benzamide 
• 782493-05-4 ethyl 3-[1-((1R,3S)-3-(1R-hydroxyethyl)-3-{[6-(trifluoromethyl)-2H-1,3-benzoxazin-3(4H)-yl]carbonyl}cyclopentyl)piperidin-4-yl]benzoate 
• 782492-16-4 C₃₃H₄₁F₃N₂O₄ 
• 782492-97-1 C₃₃H₄₁F₃N₂O₄ 
• 782492-14-2 cis ethyl 3-[1-((1R,3S)-3-isopropyl-3-{[6-(trifluoromethyl)-2H-1,3-benzoxazin-3(4H)-yl]carbonyl}cyclopentyl)piperidin-4-yl]benzoate 

Relevant articles and documents

CCR2 MODULATORS

Compounds are provided that are modulators of the CCR2 receptor. The compounds have the general formula (I) and are useful in pharmaceutical compositions, methods for the treatment of diseases and disorders involving the pathologic activtation of CCR2 receptors.

CHEMOKING RECEPTOR ANTAGONISTS

Disclosed herein are chemokine receptor antagonists of formula (I) wherein G1, X1, X2, and X3 are as defined in the specification. Compositions comprising such compounds; and methods for treating conditions and disorders using such compounds and compositions are also described.

MICROBIOCIDAL HETEROCYCLES

The present invention relates to heterocyclic compounds of formula I which have microbiocidal activity, in particular fungicidal activity as well as methods of using the compounds of formula (I) to control microbes: wherein A is x-C(R10R11

Heterocyclic cyclopentyl tetrahydroisoquinoline and tetrahydropyridopyridine modulators of chemokine receptor activity

The present invention is directed to compounds of the formula I: Wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, X, n and the broken lines are as defined herein which are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modulators of the chemokine receptor CCR-2.

Potent heteroarylpiperidine and carboxyphenylpiperidine 1-alkyl-cyclopentane carboxamide CCR2 antagonists

This report describes replacement of the 4-(4-fluorophenyl)piperidine moiety in our CCR2 antagonists with 4-heteroaryl piperidine and 4-(carboxyphenyl)-piperidine subunits. Some of the resulting analogs retained potency in our CCR2 binding assay and had i

BENZOXAZINYL-AMIDOCYCLOPENTYL-HETEROCYCLIC MODULATORS OF CHEMOKINE RECEPTORS

Cyclopentyl compounds linked to a benzoxazinyl group through an amido moiety utilizing the ring nitrogen of the benzoxazine, and further substituted with a heterocyclic moiety, such compounds represented by formula I: which are used to modulate the CCR-2 chemokine receptor to prevent or treat inflammatory and immunoregulatory disorders and diseases, allergic diseases, atopic conditions including allergic rhinitis, dermatitis, conjunctivitis, and asthma, as well as autoimmune pathologies such as rheumatoid arthritis and atherosclerosis; and pharmaceutical compositions comprising these compounds and the use of these compounds and compositions.

BENZOXAZINYL-AMIDOCYCLOPENTYL-HETEROCYCLIC MODULATORS OF CHEMOKINE RECEPTORS

Cyclopentyl compounds linked to a benzoxazinyl group through an amido moiety utilizing the ring nitrogen of the benzoxazine, and further substituted with a heterocyclic moiety, such compounds represented by formula (I): which are used to modulate the CCR-